Wuxi Apptec
Wuxi Apptec, a leading global contract research, development, and manufacturing organisation (CRDMO), is headquartered in Wuxi, China. Founded in 2000, the company has expanded its operational footprint across North America, Europe, and Asia, establishing itself as a key player in the biopharmaceutical industry. Wuxi Apptec offers a comprehensive suite of services, including drug discovery, development, and manufacturing, which are distinguished by their innovative technologies and commitment to quality. The company has achieved significant milestones, such as the establishment of multiple state-of-the-art facilities and a robust portfolio of partnerships with major pharmaceutical firms. Recognised for its market leadership, Wuxi Apptec continues to drive advancements in the life sciences sector, providing essential support to clients in bringing new therapies to market efficiently and effectively.
DitchCarbon Score
How does Wuxi Apptec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Wuxi Apptec's score of 45 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Wuxi Apptec's reported carbon emissions
In 2023, Wuxi Apptec reported total carbon emissions of approximately 680,373,980 kg CO2e, comprising 68,853,620 kg CO2e from Scope 1, 467,798,350 kg CO2e from Scope 2, and 143,722,000 kg CO2e from Scope 3 emissions. This marks a significant increase from previous years, with total emissions of about 677,626,400 kg CO2e in 2022 and 491,495,640 kg CO2e in 2021. Wuxi Apptec has set an ambitious target to reduce its greenhouse gas (GHG) emissions intensity by 25% by 2030, starting from 2023. This commitment reflects the company's proactive approach to combat climate change across all scopes of emissions. The company is currently not committed to a net-zero target but has established reduction initiatives to enhance its sustainability practices within the pharmaceuticals and biotechnology sector. Overall, Wuxi Apptec's emissions data and climate commitments illustrate its ongoing efforts to address environmental impacts while navigating the challenges of increasing operational demands.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 6,643,770 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 144,938,320 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wuxi Apptec is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
